Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators (COLLAT-COVID)

Civil Hospices of Lyon

Status: Enrolling

Conditions: Hepatocellular Carcinoma; Peritoneal Carcinoma

Treatments: Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

Study type: Observational

Funder types: Other

Identifiers

NCT05932719

69HCL20_0697

Details and patient eligibility

About

The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments).

Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.

Enrollment: 4,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients hospitalized in France for peritoneal carcinosis or hepatocellular carcinoma between 2017 and 2020.

Exclusion criteria

• Patients who did not allow the reuse of their medical data for research

Trial design

4,000 participants in 2 patient groups

Peritoneal Carcinosis

Description:

Patients hospitalized for peritoneal carcinosis between 2017 and 2020.

Treatment:

Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.

Hepatocellular Carcinoma

Description:

Patients hospitalized for hepatocellular carcinoma between 2017 and 2020.

Treatment:

Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.